Literature DB >> 11747543

Impact of the tumour bed effect on microenvironment, radiobiological hypoxia and the outcome of fractionated radiotherapy of human FaDu squamous-cell carcinoma growing in the nude mouse.

D Zips1, W Eicheler, K Brüchner, T Jackisch, P Geyer, C Petersen, A J van der Kogel, M Baumann.   

Abstract

PURPOSE: To investigate the impact of the tumour bed effect (TBE) on histological parameters of the micromilieu, radiobiological hypoxic fraction and local control after fractionated irradiation in FaDu squamous-cell carcinoma in the nude mouse. This tumour has previously shown a clear-cut TBE caused by increased necrotic cell loss at a constant cell production rate in the viable tumour compartment.
MATERIALS AND METHODS: Human FaDu tumours were studied in the NMRI nude mouse. Tumours were transplanted either into unirradiated subcutaneous (s.c.) tissues (controls) or s.c. tissues pre-irradiated with 12.5 Gy (TBE group). In both groups we measured the volume doubling time (VDT), potential doubling time (T(pot)), relative necrotic area, and in the viable tumour compartment the relative vascular area (9F1 mAb), relative hypoxic area (NITP or pimonidazole), relative perfused area (Hoechst 33342), and the perfused fraction of vasculature. The tumour control dose 50% (TCD 50), radiobiological hypoxic fraction (rHF) and dose-modifying factors (DMF) for the comparison of tumours in the TBE and control groups were determined from local tumour control data after treatment with single doses under ambient conditions or under clamp hypoxia, and after irradiation with 30 fractions under ambient conditions within 6 weeks using maximum-likelihood analysis.
RESULTS: A clear-cut TBE (VDT = 4.0 days (95%CI 2.9;4.4) for the control group versus 7.2 days (6.4;8.9) for the TBE group; p <0.0001) caused by increased necrosis (mean relative necrotic area of 12% (5;20)) versus 33% (10;41); p = 0.07) at a constant cell production rate (T(pot) = 2.2 days (1.4;2.3) versus 2.2 days (1.7;2.6); p = 0.30) was confirmed. Histological analysis of the micromilieu within the vital subarea revealed no systematic differences between the TBE and control groups. The rHF of 2% (0.1;27) for control tumours was lower than the 15% (95% CI 2;91) for the TBE group, but this difference was nonsignificant (p = 0.12). Compared with control tumours, the TCD50 for irradiation under clamped hypoxia was in a statistical trend lower for tumours in the TBE group (DMF 1.11 (0.98;1.28), p = 0.09). After fractionated irradiation, tumours of the TBE group were significantly more radiosensitive (TCD50 56.6 Gy (46;70) versus 78.7 Gy (63;100); p = 0.003).
CONCLUSIONS: The results on FaDu tumours growing in pre-irradiated tissues indicate that increased necrosis caused by impairment of the vascular supply may increase the radiosensitivity of tumours treated by fractioned irradiation.

Entities:  

Mesh:

Year:  2001        PMID: 11747543     DOI: 10.1080/09553000110073402

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  7 in total

1.  Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice.

Authors:  Mitomu Kioi; Hannes Vogel; Geoffrey Schultz; Robert M Hoffman; Griffith R Harsh; J Martin Brown
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

2.  Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas.

Authors:  Jinzhong Liu; Zhenfeng Li; Jing Cui; Gang Xu; Guanglin Cui
Journal:  Tumour Biol       Date:  2011-12-02

3.  Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.

Authors:  Olaf Penack; Erik Henke; David Suh; Chris G King; Odette M Smith; Il-Kang Na; Amanda M Holland; Arnab Ghosh; Sydney X Lu; Robert R Jenq; Chen Liu; George F Murphy; Theresa T Lu; Chad May; David A Scheinberg; Ding Cheng Gao; Vivek Mittal; Glenn Heller; Robert Benezra; Marcel R M van den Brink
Journal:  J Natl Cancer Inst       Date:  2010-05-12       Impact factor: 13.506

Review 4.  Next-generation sequencing: hype and hope for development of personalized radiation therapy?

Authors:  Ingeborg Tinhofer; Franziska Niehr; Robert Konschak; Sandra Liebs; Matthias Munz; Albrecht Stenzinger; Wilko Weichert; Ulrich Keilholz; Volker Budach
Journal:  Radiat Oncol       Date:  2015-08-28       Impact factor: 3.481

5.  Allogeneic blood transfusion given before radiotherapy is associated with the poor clinical outcome in patients with cervical cancer.

Authors:  Myong Cheol Lim; Joo-Young Kim; Tae-Hyun Kim; Sohee Park; Sun-Young Kong; Jung-Hyun Yoon; Sokbom Kang; Sang-Soo Seo; Sang Yoon Park
Journal:  Yonsei Med J       Date:  2008-12-31       Impact factor: 2.759

6.  Radiation therapy-induced tumor invasiveness is associated with SDF-1-regulated macrophage mobilization and vasculogenesis.

Authors:  Shu-Chi Wang; Ching-Fang Yu; Ji-Hong Hong; Chien-Sheng Tsai; Chi-Shiun Chiang
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

7.  Gr-1+CD11b+ cells facilitate Lewis lung cancer recurrence by enhancing neovasculature after local irradiation.

Authors:  Tao Liu; Congying Xie; Hong Ma; Sheng Zhang; Yicheng Liang; Liangliang Shi; Dandan Yu; Yiming Feng; Tao Zhang; Gang Wu
Journal:  Sci Rep       Date:  2014-04-29       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.